Page last updated: 2024-08-23

calcium oxalate and nafronyl

calcium oxalate has been researched along with nafronyl in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (57.14)18.2507
2000's2 (28.57)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aldigier, JC; Daudon, M; Leroux-Robert, C; Moesch, C; Rince, M1
Aldigier, JC; Le Meur, Y; Leroux-Robert, C; Moesch, C; Rincé, M1
Claeys, N; Cosyns, JP; Cuvelier, C; de Strihou, CV; Goffin, E; Pirson, Y; Squifflet, JP1
Bouthier, F; Charmes, JP; Leroux-Robert, C; Moesch, C1
Durand, JM; Jean-Pastor, MJ; Monestier, S; Retornaz, F; Soubeyrand, J1
Cartwight, J; Feig, D; Hicks, J; Sheikh-Hamad, D; Suki, WN; Truong, LD; Yakupoglu, U1
Kim, MJ; Kim, SW; Lee, JS1

Other Studies

7 other study(ies) available for calcium oxalate and nafronyl

ArticleYear
Renal intratubular crystallisation of calcium oxalate and naftidrofuryl oxalate.
    Lancet (London, England), 1991, Nov-09, Volume: 338, Issue:8776

    Topics: Acute Kidney Injury; Adverse Drug Reaction Reporting Systems; Calcium Oxalate; Crystallization; Humans; Kidney Tubules; Male; Middle Aged; Nafronyl

1991
Potential nephrotoxicity of intravenous infusions of naftidrofuryl oxalate.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1995, Volume: 10, Issue:9

    Topics: Acute Kidney Injury; Arteriosclerosis Obliterans; Calcium Oxalate; Crystallization; Humans; Infusions, Intravenous; Kidney; Male; Middle Aged; Nafronyl; Oxalates; Oxalic Acid; Vasodilator Agents

1995
Acute renal failure due to naftidrofuryl oxalate Praxilène overdose in a kidney transplant recipient.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1995, Volume: 10, Issue:9

    Topics: Acute Kidney Injury; Adult; Calcium Oxalate; Crystallization; Drug Overdose; Female; Humans; Infusions, Intravenous; Kidney Transplantation; Nafronyl; Peripheral Vascular Diseases; Vasodilator Agents

1995
Calcium oxalate crystalluria in elderly patients and treatment with naftidrofuryl oxalate.
    Age and ageing, 1995, Volume: 24, Issue:6

    Topics: Administration, Oral; Aged; Aged, 80 and over; Calcium Oxalate; Crystallization; Dose-Response Relationship, Drug; Female; Geriatric Assessment; Humans; Kidney Calculi; Male; Nafronyl; Vasodilator Agents

1995
Recurrent calcium oxalate nephrolithiasis induced by naftidrofuryl oxalate.
    Nephron, 2000, Volume: 85, Issue:1

    Topics: Calcium Oxalate; Female; Humans; Kidney Calculi; Middle Aged; Nafronyl; Parasympatholytics; Recurrence

2000
Calcium oxalate deposition in renal allografts: morphologic spectrum and clinical implications.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2004, Volume: 4, Issue:8

    Topics: Absorption; Adolescent; Adult; Aged; Biopsy; Cadaver; Calcium Oxalate; Creatinine; Female; Graft Rejection; Humans; Kidney Transplantation; Kidney Tubules; Living Donors; Male; Middle Aged; Nafronyl; Necrosis; Oxalates; Renal Insufficiency; Time Factors; Transplantation, Homologous; Vasodilator Agents

2004
Acute kidney injury associated with nafronyl oxalate overdose.
    Clinical and experimental nephrology, 2013, Volume: 17, Issue:3

    Topics: Acute Kidney Injury; Calcium Oxalate; Crystallization; Drug Overdose; Humans; Hyperoxaluria; Nafronyl

2013